MedPath

Treatment and Outcomes of Stage III Colon Cancer in Patients 80 Years of Age and Older

Completed
Conditions
Colon Adenocarcinoma
Interventions
Other: observational
Registration Number
NCT04526314
Lead Sponsor
Registre des Tumeurs Digestives du Finistère
Brief Summary

The objective of this study was to assess survival trends in elderly patients with stage III colon cancer

Detailed Description

This retrospective population-based study included patients aged 80 years and older with stage III colon adenocarcinoma who underwent surgery between 2007 and 2014.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
308
Inclusion Criteria

• Stage 3 colon adenocarcinoma

Exclusion Criteria
  • Rectal tumors
  • Patients receiving neo-adjuvant chemotherapy or radiotherapy
  • Tumours of the appendix
  • Tumours with histology other than adenocarcinoma

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Stage 3 with adjuvant chemotherapyobservational-
Stage 3 without adjuvant chemotherapyobservational-
Primary Outcome Measures
NameTimeMethod
Overall survival2007-2014

months

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Registre de tumeurs digestives du Finistère

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath